Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

5% more income tax returns filed this year

by AIP Online Bureau | Jan 12, 2021 | Eco/Invest/Demography, Indian News

  New Delhi: Income tax returns filed this year have risen by about 5 per cent to nearly 6 crore as more businesses and entities filed annual income statements. Over 5.95 crore income tax returns (ITRs) for the fiscal year ended March 31, 2020 (2019-20) were...

Japan passport most powerful in 2021, Pakistan continues to be in worst category: Report

by AIP Online Bureau | Jan 12, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic

  Tokyo: Even as the world continues to cope with the COVID-19 pandemic, Japan tops the list of being the most powerful passport in the world for the year 2021, according to the latest report by the Henley Passport Index. Pakistan (rank 107) and Nepal (rank 104)...

Coronavirus spurred changes to global workforce to be permanent

by AIP Online Bureau | Jan 12, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic

  Sweeping changes to the global labour market caused by the coronavirus pandemic will likely be permanent, policy makers said on Tuesday, as some industries collapse, others flourish and workers stay home.“I think it would be a fallacy to think we will go...

UN chief calls for ‘urgent transition’ from fossil fuels to renewable energy

by AIP Online Bureau | Jan 12, 2021 | Climate, Environment, Renewable Energy, Eco/Invest/Demography, International News

  All countries need credible mid-term goals and plans that are aligned with this objective", Secretary-General António Guterres said, addressing the virtual COP26 Roundtable on Clean Power Transition. "To achieve net-zero emissions by 2050, we...

GSK, Vir to test antibody for COVID-19 treatment

by AIP Online Bureau | Jan 12, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic

British drugmaker GSK and U.S.-based Vir Biotechnology will evaluate a second antibody-based treatment in patients with mild to moderate COVID-19 in an early- to mid-stage trial, the companies said on Tuesday. The new trial, supported by England's National Health...
« Older Entries
Next Entries »

Recent Posts

  • Sebi wants independent directors to adopt ‘constructive approach’
  • SC warns insurers on not taking legal action on fraud claim cases
  • Private credit sector stresses could be catastrophic, but not just yet
  • Strait of Hormuz:Trump risks confidence in U.S. role as guardian of global shipping
  • Closing Indian Protection Gap: Gaining momentum

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy